66
Views
0
CrossRef citations to date
0
Altmetric
Review

Critical analysis of the potential for the therapeutic targeting of the Sp1 transcription factor in pancreatic cancer

, &
Pages 65-74 | Published online: 17 Jun 2014

Figures & data

Figure 1 Structures of select compounds that downregulate Sp protein transcription factors in pancreatic cancer cells.

Abbreviations: CDDO, 2-cyano3,12-dioxooleana-1,9(11)-dien-28-oate; CDODA, 2-cyano-3,11-dioxo-18-olean-1,12-dien-30-oate; PEITC, phenethyl isothiocyanate; Sp, specificity protein.
Figure 1 Structures of select compounds that downregulate Sp protein transcription factors in pancreatic cancer cells.

Figure 2 BA inhibits pancreatic cancer cell growth (A) and downregulates Sp1, Sp3, and Sp4 after 24 hours treatment (B).

Abbreviations: BA, betulinic acid; Sp, specificity protein.
Figure 2 BA inhibits pancreatic cancer cell growth (A) and downregulates Sp1, Sp3, and Sp4 after 24 hours treatment (B).

Figure 3 Proposed schematic for Sp protein downregulation in pancreatic cancer.

Abbreviations: GC, GC-box; miR, microRNA; ROS, reactive oxygen species; Sp, specificity protein.
Figure 3 Proposed schematic for Sp protein downregulation in pancreatic cancer.